Skip to content

Technological Innovations in Behavioral Treatments for Cigarette Smoking

Technological Innovations in Behavioral Treatments for Cigarette Smoking

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00926939
Enrollment
96
Registered
2009-06-24
Start date
2009-06-30
Completion date
2014-08-31
Last updated
2015-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking

Keywords

Cigarette, Nicotine, Smoking, Contingency Management, Voucher reinforcement, Smoking Abstinence, Internet-based treatment

Brief summary

The purpose of the study is to evaluate a sustainable and broadly accessible treatment delivery model (Motiv8) for smoking cessation based on abstinence-reinforcement.

Detailed description

Smokers are randomly assigned to one of two groups: an Abstinence Contingent (AC) group and a Submission Contingent (SC) group. The AC group receives vouchers for abstaining from smoking (measured by a carbon monoxide monitor and confirmed through video-submission), and the SC group receives vouchers for submitting videos of their carbon monoxide breath tests. Both groups take videos of their CO-monitoring on a secure website designed for the study, as well as receive standard care counseling and education related to smoking cessation. The main intervention lasts four weeks, and a three-week maintenance phase will follow. Assessments will be conducted at intake, week four (end of the main treatment phase), and at three and six months after the intervention period is completed

Interventions

BEHAVIORALReinforcement for the abstinence of smoking

Participants in this intervention group will receive vouchers contingent upon a CO sample of 4ppm or less.

BEHAVIORALReinforcement for submission of videos with CO sample

This intervention group will receive vouchers contingent on their submission of videos of their CO breath tests.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
National Development and Research Institutes, Inc.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Self-reported smoker * Permission to contact applicant by phone * Ability to use the internet

Exclusion criteria

* Self-report of a history of or current severe or unstable medical or psychiatric illness that would interfere with the study

Design outcomes

Primary

MeasureTime frame
CO sample of ≤ 4ppm4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention
Participant reporting not smoking, not even a puff in the last 7 days.4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention

Secondary

MeasureTime frame
Twice-daily breath CO samples obtained during treatment period.First 4 weeks of treatment
The longest duration of sustained abstinence based on the twice-daily breath samples during the treatment period.First 4 weeks of treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026